v3.26.3
Stockholders' Equity (Tables)
 9 Months Ended
Sep. 30, 2026
Stockholders' Equity Note [Abstract]  
Schedule of Dividends Paid Previously or Declared
The following table presents the cash dividends either paid previously or declared by our board of directors for future payment on a per share basis during 2026 and 2025:
20262025
First quarter$0.240 $0.215 
Second quarter0.240 0.220 
Third quarter0.260 0.220 
Fourth quarter0.260 0.220 
Total$1.000 $0.875 
Stock Options Granted
The following tables summarize the details of options granted under our stock option plans that were outstanding as of September 30, 2026, and the assumptions used to value those grants. All such grants were effective at the close of business on the grant date.
Options
Granted		Option Exercise
Price		Closing Stock Price on Grant DateSeptember 30, 2026
Grant DateOptions
Outstanding		Options
Exercisable
January 2, 20261,508,081 $41.00 $40.440 1,429,866 169,011 
January 2, 20251,366,636 $36.00 $35.555 1,179,969 271,975 
January 2, 20241,629,824 $32.00 $31.775 1,303,903 485,773 
January 3, 20232,143,886 $24.00 $23.700 1,431,561 719,509 
January 3, 20221,426,876 $31.00 $30.990 857,731 585,625 
January 4, 20211,483,020 $24.00 $23.825 733,683 617,611 
January 2, 20201,804,526 $19.00 $18.615 669,769 567,753 
January 2, 20192,633,848 $13.00 $12.853 442,330 372,414 
January 2, 20182,175,872 $13.75 $13.635 224,977 224,977 
January 3, 20173,059,156 $11.75 $11.738 50,189 50,189 
Total19,231,725 8,323,978 4,064,837 
Fair Value Assumptions for Options Granted
Grant DateRisk-free
Interest Rate		Expected Life
of Option in
Years		Expected
Dividend
Yield		Expected
Stock
Volatility		Estimated Fair
Value of Stock
Option
January 2, 20263.7%5.002.2%23.79%$8.52 
January 2, 20254.3%5.002.2%27.36%$8.86 
January 2, 20243.8%5.002.2%28.44%$7.94 
January 3, 20234.0%5.002.6%29.58%$5.81 
January 3, 20221.3%5.001.7%28.52%$6.84 
January 4, 20210.4%5.002.0%29.17%$4.79 
January 2, 20201.7%5.002.4%25.70%$3.41 
January 2, 20192.5%5.002.9%23.96%$2.20 
January 2, 20182.2%5.002.3%23.45%$2.51 
January 3, 20171.9%5.002.6%24.49%$2.10 
Reconciliation of Denominators Used in Computation of Basic and Diluted Net Income Per Share
The following tables present a reconciliation of the denominators used in the computation of basic and diluted net income per share and a summary of the options to purchase shares of common stock which were excluded from the diluted net income per share calculation because they were anti-dilutive:
Nine-month PeriodThree-month Period
Reconciliation2026202520262025
Basic weighted average shares outstanding1,147,628,672 1,147,437,856 1,147,190,302 1,147,871,234 
Weighted shares assumed upon exercise of stock options2,799,555 2,814,160 2,912,053 3,165,397 
Diluted weighted average shares outstanding1,150,428,227 1,150,252,016 1,150,102,355 1,151,036,631 
Anti-Dilutive Options Excluded
Nine-month PeriodThree-month Period
Summary of Anti-dilutive Options Excluded2026202520262025
Options to purchase shares of common stock1,262,311 1,188,640 55,459 — 
Weighted average exercise prices of options$41.00 36.00 $41.00 —